Tejnaksh Healthcare's Q4 FY 2025-26 Quarterly Results

Result Summary

• Tejnaksh Healthcare Ltd reported a 0.0% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a decline of 18.2%.
• Its expenses for the quarter were down by 6.9% QoQ and 19.3% YoY.
• The net profit increased 25.0% QoQ and decreased 18.6% YoY.
• The earnings per share (EPS) of Tejnaksh Healthcare Ltd stood at 0.17 during Q4 FY 2025-26.

Financial Statments for Q4 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Tejnaksh Healthcare Ltd is a company focused on the healthcare sector, operating primarily within the medical services industry. The company provides a range of healthcare services, which may include diagnostic services, medical treatments, and hospital management. While specific recent developments or strategic initiatives are not available in the provided data, Tejnaksh Healthcare Ltd likely operates in a competitive and dynamic industry characterized by evolving healthcare needs and technological advancements. The company aims to deliver quality healthcare services to its clients, ensuring both patient care and operational efficiency.

Revenue

In the fourth quarter of the fiscal year 2026 (Q4FY26), Tejnaksh Healthcare Ltd reported a total income of ₹2.69 crores. This figure remained constant compared to the previous quarter (Q3FY26), indicating a 0.0% quarter-over-quarter (QoQ) change. However, when compared to the same quarter in the previous year (Q4FY25), there was a decrease of 18.2% year-over-year (YoY). This decline from ₹3.29 crores in Q4FY25 highlights a reduction in revenue generation over the year. Despite the YoY decline, the stability in QoQ revenue suggests a period of revenue stabilization during the last quarter.

Profitability

Tejnaksh Healthcare Ltd's profitability metrics for Q4FY26 reveal a profit before tax (PBT) of ₹0.52 crores, reflecting a 44.4% increase from ₹0.36 crores in Q3FY26. However, this represents an 11.9% decrease from ₹0.59 crores in Q4FY25. The tax expense for Q4FY26 was ₹0.17 crores, which was consistent with Q4FY25 but showed a 142.9% increase from ₹0.07 crores in the previous quarter. Consequently, the profit after tax (PAT) for Q4FY26 was ₹0.35 crores, marking a 25.0% increase QoQ and an 18.6% decrease YoY from ₹0.43 crores in Q4FY25. Earnings per share (EPS) for the quarter was ₹0.17, up 21.4% from ₹0.14 in Q3FY26, but down 19.0% from ₹0.21 in Q4FY25.

Operating Metrics

The company's total expenses for Q4FY26 were ₹2.17 crores, which is a decrease of 6.9% from ₹2.33 crores in the previous quarter (Q3FY26) and a 19.3% decrease from ₹2.69 crores in the same quarter of the previous year (Q4FY25). This reduction in expenses highlights cost management efforts during the quarter. Despite a stable total income, the reduced expenses have contributed to an improved quarter-over-quarter profitability. The financial data provided does not include specific operating metrics such as P/E ratio, debt-to-equity ratio, or current ratio, and thus these could not be analyzed. The trends in expense management and income stability are notable within the fiscal period.